Humira
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Quality by design (QbD) is an efficient but challenging approach for the development of biosimilar due to the complex…
the biggestselling drug list again in 2018, it is hard to see where any challenger might come from to snatch the autoimmune…
Objective To demonstrate clinical equivalence of adalimumab biosimilar candidate BI 695501 with Humira. Methods Patients with…
ABSTRACT Biosimilars are biological products that are highly similar to existing products approved by health authorities…
AIMS
To compare the pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a biosimilar of adalimumab, with…
In this study, efficacy, tolerability and safety of biosimilar adalimumab (Exemptia; Zydus Cadila) was compared with reference…
Aims The aim of the study was to compare the pharmacokinetics (PK), safety and tolerability of the proposed adalimumab biosimilar…
Increasing evidence from epidemiological, preclinical and clinical studies suggests that dysregulated inflammatory response plays…
Human embryos develop at varying rates in culture, with only a fraction of the eggs retrieved developing to ‘transfer quality…
FDA-Approved Indications Moderately to severely active rheumatoid arthritis (RA) Moderately to severely active polyarticular…